Total neoadjuvant therapy (TNT) for rectal cancer (UICC stages ≥ II): A highly promising approach for long-term survival to all? This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal ...
Fruquintinib combined with tislelizumab and SBRT as a later-line therapy in microsatellite stability (MSS) metastatic colorectal cancer (mCRC): Results from the FRUIT trial. This is an ASCO Meeting ...
The incidence of appendiceal adenocarcinoma in the United States more than tripled among those born in 1980 and rose more than fourfold among those born in 1985 compared with a cohort born in 1945, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results